Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 
 

Latest news from PneumoNP

Major Classes of Antibiotics

Antibiotic resistance: Hope may come from small biotech companies

Discover Adenium, a small biotech company from Denmark. It develops the molecule that may become the next generation of antibiotics ...
Read More
Graphical abstract

New publication: Experimental methods for aerosol measurements in human airways

Experimental methods for flow and aerosol measurements in human airways and their replicas Abstract Recent developments in the prediction of ...
Read More